DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Report
- Report Number
- 1416980-2014-38605
- Event Type
- Injury
- Date Received
- November 3, 2014
- Date of Event
- September 15, 2014
- Report Date
- October 9, 2014
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Product Code
- KDI
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VM
- Reporter Occupation
- NURSE
Narratives
(B)(4). THE REPORTED PRODUCT IS AN UNKNOWN BAXTER MINICAP. THE DEVICE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN, THEREFORE, A DEVICE ANALYSIS CANNOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A FOLLOW-UP WILL BE SUBMITTED. (B)(4).
IT WAS REPORTED THAT A PATIENT EXPERIENCED PERITONITIS COINCIDENT WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (PD) THERAPY MANIFESTED BY ABDOMINAL PAIN AND CLOUDY PD EFFLUENT. THE CAUSE OF PERITONITIS WAS UNKNOWN FURTHER DESCRIBED AS POOR SURROUNDING ENVIRONMENT WITH NO FURTHER DETAILS PROVIDED. ON THE SAME DAY AS ONSET, THE PATIENT WAS HOSPITALIZED FOR THE EVENT. ON THE SAME DAY AS ONSET, THE PATIENT BEGAN TREATMENT FOR THE PERITONITIS WITH CEFAZOLIN AND CEFTAZIDIME (250 MILLIGRAMS, 4 TIMES A DAY, ROUTE NOT REPORTED). TWO DAYS LATER, THE PATIENT'S TREATMENT WITH CEFAZOLIN AND CEFTAZIDIM WAS DISCONTINUED. THE FOLLOWING DAY, THE PATIENT BEGAN TREATMENT FOR PERITONITIS WITH ENTINAM (200 MILLIGRAMS, 4 TIMES A DAY, ROUTE NOT REPORTED) AND AMIKACIN (25 MILLIGRAMS, 4 TIMES A DAY, ROUTE NOT REPORTED) FOR PERITONITIS. THIRTEEN DAYS LATER, TREATMENT WITH ENTINAM AND AMIKACIN WAS DISCONTINUED. ON THE SAME DAY, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL, THE PERITONITIS WAS RESOLVED AND THE PATIENT WAS RECOVERED. AT THE TIME OF THIS REPORT, DIANEAL THERAPIES WERE ONGOING. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THIS IS REPORT 2 OF 3 INVOLVED IN THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 701578 | DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM | KDI | BAXTER HEALTHCARE CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 47 YR | Hospitalization| R | 1.5% DIANEAL PD4, 2.5% DIANEAL PD4,| TRANSFER SET, TITANIUM ADAPTER |